Minta, M.; Kurzawińska, G.; Banach Minta, Z.; Seremak Mrozikiewicz, A.; Szpecht, D.
Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study. Genes 2025, 16, 1271.
https://doi.org/10.3390/genes16111271
AMA Style
Minta M, Kurzawińska G, Banach Minta Z, Seremak Mrozikiewicz A, Szpecht D.
Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study. Genes. 2025; 16(11):1271.
https://doi.org/10.3390/genes16111271
Chicago/Turabian Style
Minta, Marcin, Grażyna Kurzawińska, Zuzanna Banach Minta, Agnieszka Seremak Mrozikiewicz, and Dawid Szpecht.
2025. "Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study" Genes 16, no. 11: 1271.
https://doi.org/10.3390/genes16111271
APA Style
Minta, M., Kurzawińska, G., Banach Minta, Z., Seremak Mrozikiewicz, A., & Szpecht, D.
(2025). Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study. Genes, 16(11), 1271.
https://doi.org/10.3390/genes16111271